Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and Cardiac Remodeling, Ventricular

daunorubicin has been researched along with Cardiac Remodeling, Ventricular in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Adamcová, M; Holečková, M; Jirkovská, A; Karabanovich, G; Kocúrová-Lengvarská, J; Kollárová-Brázdová, P; Kubeš, J; Lenčová-Popelová, O; Mazurová, Y; Roh, J; Šimůnek, T; Štěrba, M; Štěrbová-Kovaříková, P; Váňová, N1
Adamcová, M; Geršl, V; Jirkovský, E; Lenčo, J; Lenčová-Popelová, O; Mazurová, Y; Šimůnek, T; Štěrba, M1
Adamcová, M; Bureš, J; Hroch, M; Jansová, H; Jirkovská-Vávrová, A; Jirkovský, E; Kovaříková, P; Lenčová-Popelová, O; Mazurová, Y; Pokorná, Z; Reimerová, P; Šimůnek, T; Štěrba, M; Vostatková, L1
Adamcová, M; Aupperle, H; Geršl, V; Mazurová, Y; Popelová, O; Potáčová, A; Štěrba, M1
Adamcová, M; Gersl, V; Guncová, I; Mazurová, Y; Popelová, O; Potácová, A; Simůnek, T; Sterba, M1

Other Studies

5 other study(ies) available for daunorubicin and Cardiac Remodeling, Ventricular

ArticleYear
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
    Clinical science (London, England : 1979), 2021, 08-13, Volume: 135, Issue:15

    Topics: Animals; Cardiomyopathies; Cardiotoxicity; Chronic Disease; Daunorubicin; Diketopiperazines; Disease Models, Animal; DNA Damage; Fibrosis; HL-60 Cells; Humans; Male; Myocytes, Cardiac; Prodrugs; Rabbits; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2021
Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Animals; Anthracyclines; Blotting, Western; Daunorubicin; Echocardiography; Immunohistochemistry; Intermediate Filaments; Male; Myocardium; Rabbits; Real-Time Polymerase Chain Reaction; Transcription Factors; Troponin T; Ventricular Remodeling

2014
Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
    Toxicology, 2016, Nov-30, Volume: 372

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Cell Line, Tumor; Cell Proliferation; Chronic Disease; Daunorubicin; Doxorubicin; Heart Diseases; Heart Failure; Lipid Peroxidation; Molsidomine; Nitric Oxide Donors; Oxidative Stress; Rabbits; Reactive Oxygen Species; Ventricular Remodeling

2016
Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits.
    Physiological research, 2010, Volume: 59, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiovascular Agents; Chronic Disease; Collagen; Daunorubicin; Disease Models, Animal; Drug Interactions; Fibrosis; Hydroxyproline; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Rabbits; Razoxane; Ventricular Remodeling

2010
A pilot study of matrix metalloproteinases on the model of daunorubicin-induced cardiomyopathy in rabbits.
    Acta medica (Hradec Kralove), 2007, Volume: 50, Issue:2

    Topics: Animals; Cardiomyopathies; Collagen; Daunorubicin; Matrix Metalloproteinases; Rabbits; Troponin T; Ventricular Remodeling

2007